Positron Corporation (POSC)
USD 1.57
(-16.49%)
USD 1.57
(-16.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.45 Million USD | 50.06% |
| 2022 | -2.77 Million USD | -258.37% |
| 2021 | -568.42 Thousand USD | -1813.08% |
| 2020 | -38.51 Thousand USD | -5826.15% |
| 2019 | -656.00 USD | -102.94% |
| 2018 | 22.11 Thousand USD | 0.0% |
| 2014 | -609 Thousand USD | 18.47% |
| 2013 | -4.8 Million USD | 29.31% |
| 2012 | -5.89 Million USD | -4.19% |
| 2011 | -4.85 Million USD | 70.04% |
| 2010 | -10.83 Million USD | -199.09% |
| 2009 | -4.31 Million USD | -8.23% |
| 2008 | -8.23 Million USD | -10.48% |
| 2007 | -7.56 Million USD | -319.92% |
| 2006 | -3.11 Million USD | 62.24% |
| 2005 | -2.29 Million USD | -91.84% |
| 2004 | -1.32 Million USD | 63.93% |
| 2003 | -1.29 Million USD | -68.39% |
| 2002 | -2.43 Million USD | 36.39% |
| 2001 | -3.44 Million USD | 0.67% |
| 2000 | -1.97 Million USD | -116.17% |
| 1999 | -1.62 Million USD | -6484.0% |
| 1998 | 38 Thousand USD | 100.72% |
| 1997 | -3.65 Million USD | 39.4% |
| 1996 | -5.87 Million USD | -21.51% |
| 1995 | -4.8 Million USD | -14.63% |
| 1994 | -4.1 Million USD | -70.83% |
| 1993 | -2.4 Million USD | -166.67% |
| 1992 | -600 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -478.25 Thousand USD | -40.1% |
| 2023 Q4 | -363.97 Thousand USD | 21.78% |
| 2023 Q1 | -221.12 Thousand USD | -204.53% |
| 2023 Q3 | -465.3 Thousand USD | -73.32% |
| 2023 FY | - USD | 50.06% |
| 2023 Q2 | -268.47 Thousand USD | -21.41% |
| 2022 Q3 | -515.37 Thousand USD | -218.31% |
| 2022 Q1 | -1.34 Million USD | -2275.57% |
| 2022 FY | - USD | -258.37% |
| 2022 Q2 | -161.91 Thousand USD | 87.93% |
| 2022 Q4 | -72.61 Thousand USD | 85.91% |
| 2021 Q4 | 61.64 Thousand USD | 128.33% |
| 2021 Q3 | -217.56 Thousand USD | 33.07% |
| 2021 Q2 | -325.06 Thousand USD | -27.01% |
| 2021 Q1 | -255.94 Thousand USD | 0.0% |
| 2021 FY | - USD | -1813.08% |
| 2020 FY | - USD | -5826.15% |
| 2020 Q2 | -18.89 Thousand USD | 0.0% |
| 2019 FY | - USD | -102.94% |
| 2018 FY | - USD | 0.0% |
| 2015 Q1 | -491 Thousand USD | 18.71% |
| 2015 Q3 | -138 Thousand USD | 29.95% |
| 2015 Q2 | -197 Thousand USD | 59.88% |
| 2014 Q2 | -669 Thousand USD | -3.08% |
| 2014 FY | - USD | 18.47% |
| 2014 Q4 | -604 Thousand USD | 9.72% |
| 2014 Q3 | -669 Thousand USD | 0.0% |
| 2014 Q1 | -649 Thousand USD | 43.02% |
| 2013 Q1 | -722 Thousand USD | 56.06% |
| 2013 Q2 | -625 Thousand USD | 13.43% |
| 2013 FY | - USD | 29.31% |
| 2013 Q3 | -693 Thousand USD | -10.88% |
| 2013 Q4 | -1.13 Million USD | -64.36% |
| 2012 Q3 | -743 Thousand USD | 31.33% |
| 2012 FY | - USD | -4.19% |
| 2012 Q2 | -1.08 Million USD | 38.31% |
| 2012 Q4 | -1.64 Million USD | -121.13% |
| 2012 Q1 | -1.75 Million USD | -80.45% |
| 2011 Q3 | -1.08 Million USD | 30.08% |
| 2011 FY | - USD | 70.04% |
| 2011 Q4 | -972 Thousand USD | 10.08% |
| 2011 Q2 | -1.54 Million USD | -115.92% |
| 2011 Q1 | -716 Thousand USD | 53.66% |
| 2010 Q1 | -3.14 Million USD | -38.92% |
| 2010 FY | - USD | -199.09% |
| 2010 Q3 | -2.62 Million USD | 62.59% |
| 2010 Q4 | -1.54 Million USD | 41.12% |
| 2010 Q2 | -7.01 Million USD | -123.34% |
| 2009 FY | - USD | -8.23% |
| 2009 Q3 | -1.18 Million USD | -141.26% |
| 2009 Q2 | -492 Thousand USD | -125.69% |
| 2009 Q1 | -218 Thousand USD | 81.09% |
| 2009 Q4 | -2.26 Million USD | -90.48% |
| 2008 Q2 | 408 Thousand USD | 122.05% |
| 2008 Q3 | -1.76 Million USD | -532.84% |
| 2008 Q4 | -1.15 Million USD | 34.71% |
| 2008 Q1 | -1.85 Million USD | -72.09% |
| 2008 FY | - USD | -10.48% |
| 2007 FY | - USD | -319.92% |
| 2007 Q4 | -1.07 Million USD | -10.71% |
| 2007 Q1 | -988 Thousand USD | 33.42% |
| 2007 Q2 | -961 Thousand USD | 2.73% |
| 2007 Q3 | -971 Thousand USD | -1.04% |
| 2006 Q2 | 1.27 Million USD | 300.0% |
| 2006 FY | - USD | 62.24% |
| 2006 Q1 | -639 Thousand USD | 34.99% |
| 2006 Q3 | -114 Thousand USD | -108.92% |
| 2006 Q4 | -1.48 Million USD | -1201.75% |
| 2005 FY | - USD | -91.84% |
| 2005 Q4 | -983 Thousand USD | -183.29% |
| 2005 Q2 | -456 Thousand USD | 9.52% |
| 2005 Q3 | -347 Thousand USD | 23.9% |
| 2005 Q1 | -504 Thousand USD | -15.6% |
| 2004 Q1 | -224 Thousand USD | 40.74% |
| 2004 Q3 | -81 Thousand USD | 65.24% |
| 2004 Q4 | -436 Thousand USD | -438.27% |
| 2004 FY | - USD | 63.93% |
| 2004 Q2 | -233 Thousand USD | -4.02% |
| 2003 Q2 | -472 Thousand USD | -3411.63% |
| 2003 Q4 | -378 Thousand USD | 28.81% |
| 2003 FY | - USD | -68.39% |
| 2003 Q3 | -531 Thousand USD | 81.36% |
| 2003 Q1 | 86 Thousand USD | 124.23% |
| 2002 Q4 | -535 Thousand USD | 41.42% |
| 2002 Q1 | -383 Thousand USD | 77.94% |
| 2002 Q2 | -736 Thousand USD | -118.28% |
| 2002 Q3 | -606 Thousand USD | 27.51% |
| 2002 FY | - USD | 36.39% |
| 2001 Q1 | -662 Thousand USD | -5.41% |
| 2001 Q4 | -1.73 Million USD | -271.73% |
| 2001 Q2 | -575 Thousand USD | 13.14% |
| 2001 FY | - USD | 0.67% |
| 2001 Q3 | -467 Thousand USD | 18.78% |
| 2000 Q3 | 518 Thousand USD | -526.89% |
| 2000 FY | - USD | -116.17% |
| 2000 Q2 | -357 Thousand USD | -57.27% |
| 2000 Q1 | -227 Thousand USD | 0.0% |
| 2000 Q4 | -921 Thousand USD | 71.94% |
| 1999 FY | - USD | -6484.0% |
| 1998 FY | - USD | 100.72% |
| 1997 Q1 | -1.1 Million USD | 69.0% |
| 1997 FY | - USD | 39.4% |
| 1996 Q3 | -900 Thousand USD | 38.46% |
| 1996 Q4 | -2.17 Million USD | -343.5% |
| 1996 FY | - USD | -21.51% |
| 1996 Q2 | -1.4 Million USD | 38.1% |
| 1996 Q1 | -2.1 Million USD | -75.0% |
| 1995 Q2 | -600 Thousand USD | 60.0% |
| 1995 Q1 | -1.5 Million USD | -50.0% |
| 1995 Q4 | -1.4 Million USD | 20.0% |
| 1995 Q3 | -1.5 Million USD | -150.0% |
| 1995 FY | - USD | -14.63% |
| 1994 Q2 | -1.1 Million USD | -20.0% |
| 1994 Q1 | -900 Thousand USD | 87.5% |
| 1994 FY | - USD | -70.83% |
| 1994 Q3 | -1 Million USD | 8.33% |
| 1994 Q4 | -1 Million USD | 9.09% |
| 1993 Q3 | 1.9 Million USD | 5.56% |
| 1993 Q2 | 1.8 Million USD | 0.0% |
| 1993 FY | - USD | -166.67% |
| 1993 Q4 | -8 Million USD | -521.05% |
| 1993 Q1 | 1.8 Million USD | 134.62% |
| 1992 Q3 | 1.7 Million USD | 6.25% |
| 1992 Q4 | -5.2 Million USD | -405.88% |
| 1992 FY | - USD | 0.0% |
| 1992 Q1 | 1.6 Million USD | 0.0% |
| 1992 Q2 | 1.6 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -429.422% |
| IR-Med Inc. | -4.89 Million USD | 70.316% |
| Polarean Imaging plc | -11.19 Million USD | 87.029% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 418.412% |
| Avitar, Inc. | -1.66 Million USD | 12.93% |
| AVITA Medical, Inc. | -39.56 Million USD | 96.33% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -24.755% |
| Össur hf. | 137.38 Million USD | 101.057% |
| Zecotek Photonics Inc. | -3.44 Million USD | 57.814% |
| QHSLab, Inc. | -91.29 Thousand USD | -1490.649% |
| Wellstar International, Inc. | -1.35 Million USD | -7.05% |
| Össur hf. | 137.38 Million USD | 101.057% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 114.857% |
| Escalon Medical Corp. | -58.46 Thousand USD | -2383.965% |
| Aurora Spine Corporation | -454.37 Thousand USD | -219.591% |
| BrainsWay Ltd. | -2.31 Million USD | 37.164% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 84.518% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 126.299% |
| Vivos Inc. | -2.79 Million USD | 48.01% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.582% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -634.556% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 12.969% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -283.248% |
| Nanomix Corporation | -8.13 Million USD | 82.16% |
| Theraclion SA | -2.05 Million USD | 29.191% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -105.387% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 15.665% |
| Lombard Medical, Inc. | -28.06 Million USD | 94.826% |
| ALR Technologies Inc. | -6.4 Million USD | 77.311% |
| Stratec SE | 39.91 Million USD | 103.638% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 1538.585% |
| Heart Tronics, Inc. | -14.85 Million USD | 90.226% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -1127.941% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 89.063% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 84.133% |
| VMS Rehab Systems, Inc. | -68.55 USD | -2118282.203% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 53.546% |
| Ingen Technologies, Inc. | -8639.00 USD | -16709.249% |
| Odyssey Group International, Inc. | -2.13 Million USD | 32.081% |
| United American Healthcare Corporation | -59 Thousand USD | -2361.273% |
| ECGI Holdings, Inc. | -2.99 Million USD | 51.44% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -130.799% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -182.506% |
| Urologix, Inc. | -6.34 Million USD | 77.11% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -17.169% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -89.584% |
| SS Innovations International, Inc. | -20.37 Million USD | 92.873% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -551.721% |
| Smith & Nephew plc | 1 Billion USD | 100.145% |
| NIOX Group Plc | 11.07 Million USD | 113.112% |
| Fuse Medical, Inc. | 1.83 Million USD | 179.123% |
| Broncus Holding Corporation | -25.19 Million USD | 94.237% |
| Brain Scientific Inc. | -7.93 Million USD | 81.696% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 84.537% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -7792.125% |